Conditions & Recovery · NY Times Health · September 30, 2026

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Related learning